A detailed history of Huntington National Bank transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Huntington National Bank holds 3,663 shares of TEVA stock, worth $63,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,663
Previous 3,637 0.71%
Holding current value
$63,955
Previous $51,000 15.69%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$12.78 - $17.4 $332 - $452
26 Added 0.71%
3,663 $59,000
Q4 2023

Feb 07, 2024

SELL
$8.12 - $10.63 $64 - $85
-8 Reduced 0.22%
3,637 $37,000
Q2 2023

Aug 11, 2023

SELL
$7.2 - $9.47 $3,772 - $4,962
-524 Reduced 12.57%
3,645 $27,000
Q1 2023

May 10, 2023

BUY
$8.36 - $11.37 $4,447 - $6,048
532 Added 14.63%
4,169 $36,000
Q3 2022

Nov 07, 2022

BUY
$6.86 - $11.95 $246 - $430
36 Added 1.0%
3,637 $29,000
Q1 2022

May 10, 2022

SELL
$7.33 - $9.39 $9,155 - $11,728
-1,249 Reduced 25.75%
3,601 $33,000
Q4 2021

Jan 21, 2022

BUY
$7.9 - $10.19 $20,547 - $26,504
2,601 Added 115.65%
4,850 $38,000
Q3 2021

Oct 28, 2021

BUY
$8.38 - $10.18 $8,380 - $10,180
1,000 Added 80.06%
2,249 $22,000
Q2 2021

Jul 30, 2021

SELL
$9.9 - $11.56 $9,900 - $11,560
-1,000 Reduced 44.46%
1,249 $12,000
Q4 2020

Jan 11, 2021

SELL
$8.61 - $11.04 $1,937 - $2,484
-225 Reduced 9.09%
2,249 $22,000
Q3 2020

Oct 30, 2020

BUY
$8.57 - $12.69 $1,491 - $2,208
174 Added 7.57%
2,474 $22,000
Q1 2020

Apr 27, 2020

SELL
$6.69 - $13.45 $15,547 - $31,257
-2,324 Reduced 50.26%
2,300 $20,000
Q4 2019

Jan 17, 2020

BUY
$6.53 - $10.72 $8,449 - $13,871
1,294 Added 38.86%
4,624 $45,000
Q3 2019

Nov 01, 2019

SELL
$6.16 - $9.6 $1,139 - $1,776
-185 Reduced 5.26%
3,330 $23,000
Q2 2019

Jul 23, 2019

SELL
$8.12 - $15.72 $1,339 - $2,593
-165 Reduced 4.48%
3,515 $33,000
Q1 2019

Apr 09, 2019

BUY
$15.58 - $20.01 $26,875 - $34,517
1,725 Added 88.24%
3,680 $57,000
Q4 2018

Jan 28, 2019

SELL
$14.59 - $23.84 $12,518 - $20,454
-858 Reduced 30.5%
1,955 $30,000
Q3 2018

Oct 18, 2018

SELL
$21.06 - $25.65 $11,119 - $13,543
-528 Reduced 15.8%
2,813 $61,000
Q2 2018

Jul 19, 2018

SELL
$16.77 - $24.71 $21,633 - $31,875
-1,290 Reduced 27.86%
3,341 $82,000
Q1 2018

Apr 30, 2018

SELL
$16.68 - $22.07 $18,648 - $24,674
-1,118 Reduced 19.45%
4,631 $79,000
Q4 2017

Feb 02, 2018

SELL
$11.23 - $19.1 $62,955 - $107,074
-5,606 Reduced 49.37%
5,749 $109,000
Q3 2017

Oct 24, 2017

BUY
$15.41 - $32.17 $174,980 - $365,290
11,355
11,355 $199,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.